Skip to content

Free Neurovascularized Muscle Transfer in Facial Reanimation of Long-standing Facial Palsy Patients

Segmental Free Latissimus Versus Free Gracillis Muscles Powered by Hypoglossal Nerve in Facial Reanimation of Long-standing Facial Palsy Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05222698
Enrollment
20
Registered
2022-02-03
Start date
2022-04-30
Completion date
2024-12-31
Last updated
2022-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Paralysis

Brief summary

The use of free Neurovascularized muscles like free latissimus and gracillis muscles for reanimation of long-standing facial palsy patients using the hypoglossal nerve for innervating these muscles

Detailed description

The investigators need to know which of the two muscles is better functionally and aesthetically in facial reanimation of patients with facial paralysis of more than one year duration.

Interventions

PROCEDUREFacial reanimation surgery by free muscle trasfer.

Muscle flap harvesting from the back or from the thigh to be insetted to the paralyzed side of the face with microvascular anastomosis of the muscle pedicle to facial artery and vein.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* All patients with facial paralysis more than one year what ever the cause.

Exclusion criteria

* patients with uncontrolled diabetes.

Design outcomes

Primary

MeasureTime frameDescription
Change in smile excursion with the two muscles in the paralyzed side from the pre operative state.One year post operatively.We will use SMILE system of Bray et al for assessment.

Contacts

Primary ContactAhmed Saber, Master
ahmed.osman@med.sohag.edu.eg01005795166

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026